Cyclerion Therapeutics (CYCN) Treasury Shares (2019 - 2025)
Cyclerion Therapeutics (CYCN) recorded quarterly Treasury Shares of $104078.0 in Q4 2025, down 12.61% quarter-over-quarter from $119102.0 in Q3 2025, and down 36.61% on a YoY basis from $164174.0 in Q4 2024.
Cyclerion Therapeutics (CYCN) Treasury Shares (2019 - 2025) Analysis & Trends
Cyclerion Therapeutics' Treasury Shares history runs 7 years deep, the most recent figure standing at $104078.0 for Q4 2025.
- In Q4 2025, Treasury Shares fell 36.61% year-over-year to $104078.0; the TTM figure through Dec 2025 stood at $104078.0 (down 36.61% YoY), while the FY2025 annual figure was $104078.0, down 36.61% from the prior year.
- Treasury Shares was $104078.0 for Q4 2025 at Cyclerion Therapeutics, down from $119102.0 in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $809417.0 in Q1 2023 to a low of $34362.0 in Q2 2023.
- Historically, Treasury Shares has averaged $156741.2 across 5 years, with a median of $129740.5 in 2021.
- The sharpest annual moves came in 2022 and 2024: Treasury Shares slumped 74.6% in 2022, then surged 465.22% in 2024.
- A 5-year view of Treasury Shares shows it stood at $92804.0 in 2021, then slumped by 56.07% to $40772.0 in 2022, then jumped by 319.25% to $170937.0 in 2023, then slipped by 3.96% to $164174.0 in 2024, then sank by 36.61% to $104078.0 in 2025.
- The last three Treasury Shares figures came in at $104078.0 (Q4 2025), $119102.0 (Q3 2025), and $134126.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | 1.48 Mn |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 700,000.00 |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | - |
| 10 | Cyclerion Therapeutics | 11.50 Mn | 8.26 Mn | - | 104,078.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 104,078.00 |
| Dec 31, 2025 | 104,078.00 |
| Sep 30, 2025 | 119,102.00 |
| Sep 30, 2025 | 119,102.00 |
| Jun 30, 2025 | 134,126.00 |
| Jun 30, 2025 | 134,126.00 |
| Mar 31, 2025 | 149,150.00 |
| Mar 31, 2025 | 149,150.00 |
| Dec 31, 2024 | 164,174.00 |
| Dec 31, 2024 | 164,174.00 |
| Sep 30, 2024 | 179,198.00 |
| Sep 30, 2024 | 179,198.00 |
| Jun 30, 2024 | 194,222.00 |
| Jun 30, 2024 | 194,222.00 |
| Mar 31, 2024 | 210,495.00 |
| Mar 31, 2024 | 210,495.00 |
| Dec 31, 2023 | 170,937.00 |
| Dec 31, 2023 | 170,937.00 |
| Jun 30, 2023 | 34,362.00 |
| Jun 30, 2023 | 34,362.00 |